GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 18.95
-0.14 (-0.73%)
At close: Sep 10, 2025
GemPharmatech Revenue
GemPharmatech had revenue of 203.95M CNY in the quarter ending June 30, 2025, with 11.27% growth. This brings the company's revenue in the last twelve months to 721.26M, up 8.18% year-over-year. In the year 2024, GemPharmatech had annual revenue of 686.84M with 10.39% growth.
Revenue (ttm)
721.26M
Revenue Growth
+8.18%
P/S Ratio
10.41
Revenue / Employee
457.07K
Employees
1,578
Market Cap
7.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 686.84M | 64.65M | 10.39% |
| Dec 31, 2023 | 622.19M | 105.64M | 20.45% |
| Dec 31, 2022 | 516.55M | 122.76M | 31.17% |
| Dec 31, 2021 | 393.79M | 131.87M | 50.35% |
| Dec 31, 2020 | 261.92M | 69.20M | 35.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |